VPIM
CYTO

Vanguard Personalized Indexing Management’s Altamira Therapeutics Ltd CYTO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26
Closed -$5K – 1324
2022
Q2 		$5K Buy
+26
New +$8.39K ﹤0.01% 1254

Other funds holding CYTO

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Personalized Indexing Management's CYTO Position: Q3 2022 in Review

Vanguard Personalized Indexing Management sold out of Altamira Therapeutics Ltd (CYTO) in Q3 2022, closing a stake of 26 shares — an estimated $5K sold.

Vanguard Personalized Indexing Management first reported a position in CYTO in Q2 2022 and held it in 1 quarter. The position peaked at $5K in Q2 2022. 13 funds tracked by Wall St. Rank hold CYTO as of Q3 2022.

  • Vanguard Personalized Indexing Management reported no remaining Altamira Therapeutics Ltd position as of Q3 2022 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 26 Altamira Therapeutics Ltd shares in Q3 2022, an estimated $5K.
  • Vanguard Personalized Indexing Management first reported a position in Altamira Therapeutics Ltd in Q2 2022 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Altamira Therapeutics Ltd position peaked at $5K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q3 2022.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2022, filed 14 Nov 2022.